Follow
Sandra J Aedo
Sandra J Aedo
Verified email at princeton.edu
Title
Cited by
Cited by
Year
High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4)
SM Hamilton, JAN Alexander, EJ Choo, L Basuino, TM da Costa, ...
Antimicrobial Agents and Chemotherapy 61 (6), e02727-16, 2017
752017
Role of the stringent stress response in the antibiotic resistance phenotype of methicillin-resistant Staphylococcus aureus
S Aedo, A Tomasz
Antimicrobial agents and chemotherapy 60 (4), 2311-2317, 2016
672016
Plasmid-related quinolone resistance determinants in epidemic Vibrio parahaemolyticus, uropathogenic Escherichia coli, and marine bacteria from an aquaculture area in Chile
S Aedo, L Ivanova, A Tomova, FC Cabello
Microbial ecology 68 (2), 324-328, 2014
502014
The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining
G Narula, T Annamalai, S Aedo, B Cheng, E Sorokin, A Wong, ...
Journal of Biological Chemistry 286 (21), 18673-18680, 2011
382011
Asp-to-Asn Substitution at the First Position of the DxD TOPRIM Motif of Recombinant Bacterial Topoisomerase I Is Extremely Lethal to E. coli
B Cheng, T Annamalai, E Sorokin, M Abrenica, S Aedo, YC Tse-Dinh
Journal of molecular biology 385 (2), 558-567, 2009
352009
Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region
EP Sorokin, B Cheng, S Rathi, SJ Aedo, MV Abrenica, YC Tse-Dinh
Nucleic acids research 36 (14), 4788-4796, 2008
312008
Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA
S Aedo, YC Tse-Dinh
Antimicrobial agents and chemotherapy 56 (11), 5458-5464, 2012
302012
Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
SJ Aedo, MA Orman, MP Brynildsen
BMC Microbiology 19 (1), 140, 2019
172019
Metabolites potentiate nitrofurans in non-growing Escherichia coli
SJ Aedo, J Tang, MP Brynildsen
Antimicrobial Agents and Chemotherapy, 2020
122020
SbcCD-mediated processing of covalent gyrase-DNA complex in Escherichia coli
S Aedo, YC Tse-Dinh
Antimicrobial agents and chemotherapy 57 (10), 5116-5119, 2013
122013
Checks and Balances with Use of the Keio Collection for Phenotype Testing
SJ Aedo, HR Ma, MP Brynildsen
Microbial Metabolic Engineering, 125-138, 2019
82019
Resistance to topoisomerase cleavage complex induced lethality in Escherichia coli via titration of transcription regulators PurR and FNR
IF Liu, S Aedo, YC Tse-Dinh
BMC microbiology 11 (1), 261, 2011
32011
Best Practices for Microbial Challenge In–use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
C Zamiri, DL Leiske, PF Hughes, JP Kirwan, E Der, E Cox, R Warburton, ...
PDA Journal of Pharmaceutical Science and Technology, 2023
22023
Tackling host–circuit give and take
SJ Aedo, G Gelderman, MP Brynildsen
Nature microbiology 2 (12), 1584, 2017
12017
Study of Stabilized Toposiomerase-DNA Complexes in Escherichia Coli
SJA Almonacid
New York Medical College, 2013
2013
Identification of Escherichia coli processing activities for covalent topoisomerase-DNA complexes
S Aedo, YC Tse-Dinh
The FASEB Journal 25 (1 Supplement), 500.1-500.1, 2011
2011
" VIGILANCIA DE LA RESISTENCIA DE Escherichia coli, A LOS ANTIBACTERIANOS DE MAYOR USO EN INFECCIONES URINARIAS, AISLADA EN LA COMUNIDAD INTRAHOSPITALARIA Y EXTRAHOSPITALARIA …
SJA ALMONACID
The system can't perform the operation now. Try again later.
Articles 1–17